Candel Therapeutics (CADL)

• Market cap: $277M
• 1 day: 2.02%
• 5 days: -5.79%
• 1 month: -10.48%
• 3 months: -13.7%
• 6 months: 11.01%
• Year to date: -43.94%
• 1 year: -0.98%
• 5 years: -28%
• 10 years: -28%
• Sector: Healthcare
• Industry: Biotechnology

About: Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Employees: 38